April 03, 2026 03:45 pm (IST)
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Big milestone for Bharti Airtel: 650 million users and counting
Fri, Apr 03 2026
Big deal in dairy world: Magnum Ice Cream Company takes control over popular Indian brand Kwality Wall’s
Fri, Apr 03 2026
Personal loans for lifestyle and planned expenses: An overview
Fri, Apr 03 2026
Sensex recovers from over 1,500-point crash to end higher; Nifty rebounds amid Iran tensions
Thu, Apr 02 2026
Market mayhem: Trump’s Iran strike warning rattles Dalal Street, Sensex crashes 1,500 pts
Thu, Apr 02 2026
Fuel prices rise: Premium petrol, diesel hiked amid oil price surge
Wed, Apr 01 2026
